248 related articles for article (PubMed ID: 21161341)
1. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer.
Cichon MA; Degnim AC; Visscher DW; Radisky DC
J Mammary Gland Biol Neoplasia; 2010 Dec; 15(4):389-97. PubMed ID: 21161341
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
3. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
5. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.
Martins D; Beça FF; Sousa B; Baltazar F; Paredes J; Schmitt F
Cell Cycle; 2013 Aug; 12(16):2684-90. PubMed ID: 23907124
[TBL] [Abstract][Full Text] [Related]
6. Hormones and progeny of breast tumor cells.
Schneider HP; Böcker W
Climacteric; 2006 Apr; 9(2):88-107. PubMed ID: 16698656
[TBL] [Abstract][Full Text] [Related]
7. Nuclear cytometric changes in breast carcinogenesis.
Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.
Abba MC; Drake JA; Hawkins KA; Hu Y; Sun H; Notcovich C; Gaddis S; Sahin A; Baggerly K; Aldaz CM
Breast Cancer Res; 2004; 6(5):R499-513. PubMed ID: 15318932
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion.
Dang TT; Prechtl AM; Pearson GW
Cancer Res; 2011 Nov; 71(21):6857-66. PubMed ID: 21908556
[TBL] [Abstract][Full Text] [Related]
10. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
11. Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.
Schedin P; Borges V
Breast Cancer Res; 2009; 11(2):102. PubMed ID: 19344495
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of microinvasive breast cancer microenvironment progression.
Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
[TBL] [Abstract][Full Text] [Related]
13. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
[TBL] [Abstract][Full Text] [Related]
14. High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.
Rennstam K; Hedenfalk I
Breast Cancer Res; 2006; 8(4):213. PubMed ID: 16895590
[TBL] [Abstract][Full Text] [Related]
15. Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion.
Man YG
Med Hypotheses; 2007; 69(6):1340-57. PubMed ID: 17493765
[TBL] [Abstract][Full Text] [Related]
16. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
17. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
18. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
19. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.
Rudland PS; Leinster SJ; Winstanley J; Green B; Atkinson M; Zakhour HD
J Histochem Cytochem; 1993 Apr; 41(4):543-53. PubMed ID: 8450194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]